Top Markets
Coin of the day
ASLAN Pharmaceuticals Limited ASLAN Pharmaceuticals Limited

ASLAN Pharmaceuticals Limited

ASLN
Κατάταξη σε μετοχές #37031
ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the... ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the clinical stage, primarily focused on immunology, and dedicated to creating innovative treatments that profoundly enhance patients' lives. Its advanced therapeutic pipeline features ASLAN004, a monoclonal antibody currently being evaluated for atopic dermatitis and a range of other immunological disorders. Also under development is ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase, intended to treat autoimmune conditions. The company is involved in a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd., aimed at pioneering immuno-oncology therapeutics that target the AhR pathway. Furthermore, ASLAN maintains partnerships with various entities, including Almirall, Array BioPharma, and CSL Limited. Established in 2010, the company's headquarters are located in Singapore.
Τιμή μετοχής
$0.6
Τελευταίος συγχρονισμός: 2024-08-14
Κεφαλαιοποίηση
$2.09M
Αλλαγή (1 ημέρα)
0.00%
Αλλαγή (1 έτος)
0.00%
Χώρα
SG
Εμπόριο ASLAN Pharmaceuticals Limited (ASLN)

Κατηγορία

Ιστορικό τιμής μετοχής για την ASLAN Pharmaceuticals Limited (ASLN)
Υψηλότερη τιμή κλεισίματος: $0.60 στις 2024-08-01

Χαμηλότερη τιμή κλεισίματος: $257.66 στις 2018-05-01
Ιστορικό τιμής μετοχής της ASLAN Pharmaceuticals Limited από 2018 έως 2026
Ετήσια απόδοση τιμής μετοχής
Έτος Απόδοση
2024 -84.73%
2023 -78.55%
2022 -63.40%
2021 -35.93%
2020 -19.58%
2019 -41.35%
2018 0.00%
Τιμή μετοχής για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία Τιμή μετοχής Μεταβολή 1Έτ% Χώρα
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE